FDA approves painkiller designed to eliminate risk of addiction

This photo provided by Vertex Pharmaceuticals in January 2025 shows a tablet and bottle of the JOURNAVX (suzetrigine) medication.

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.